In DKD patients, elevated circulating Pentraxin 3 (PTX3), an acute-phase reactant that reflects endothelial dysfunction, may be used as a biomarker in detecting early renal damage [50]. This evidence concerns the gene PTX3 and endothelial dysfunction.